Clinical trial
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups With Rheumatic Diseases
NCT06469788 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups With Rheumatic Diseases
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 18, 2024
- Completion date
- May 31, 2028
- Enrollment
- 1,170 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune diseases, rheumatologic disease